跳至主要内容
临床试验/NL-OMON39820
NL-OMON39820已完成不适用

Hemophilia Inhibitor PUP Study - HIPS

niversity of Texas Health Science Center0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • 1. An informed consent, approved by the appropriate Institutional Review Board (IRB)/Independent Ethics Committee (IEC), has been administered, signed, and dated.
  • 2. Subject has severe hemophilia A defined by a baseline FVIII:C <0.01 IU/ml. His FVIII activity will be confirmed at the central laboratory. If the confirmatory level is >=0.01 IU/ml the child must exit the study.
  • 3. Subject weighs 3.5 kg or more at the time of his baseline study evaluation

排除标准

  • 1. Subject has had prior exposure to clotting factor concentrates or blood products, including packed red blood cells (RBC), platelets, plasma, or cryoprecipitate.
  • 2. Subject has a clinically significant chronic disease other than hemophilia A.
  • 3. Subject is currently participating in another investigational drug study.

研究者

发起方
niversity of Texas Health Science Center

相似试验